These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 6430606

  • 21. Hypothalamic growth hormone releasing factor deficiency following cranial irradiation.
    Ahmed SR, Shalet SM.
    Clin Endocrinol (Oxf); 1984 Nov; 21(5):483-8. PubMed ID: 6437704
    [Abstract] [Full Text] [Related]

  • 22. Magnetic resonance and the diagnosis of short stature of hypothalamic-hypophyseal origin.
    Vannelli S, Avataneo T, Benso L, Potenzoni F, Cirillo S, Mostert M, Bona G.
    Acta Paediatr; 1993 Feb; 82(2):155-61. PubMed ID: 8477160
    [Abstract] [Full Text] [Related]

  • 23. Plasma growth hormone (GH) responses to growth hormone releasing factor (hp GRF 1-44) in familial GH deficiency.
    Kibirige MS, Price DA, Shalet SM, Bailie GR.
    Acta Paediatr Scand; 1987 Jan; 76(1):103-6. PubMed ID: 3105240
    [Abstract] [Full Text] [Related]

  • 24. Defective response of plasma growth hormone to growth hormone releasing factor in growth hormone deficient children.
    Ko FY, Chen WP, Lin CY.
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1992 Jan; 33(4):243-50. PubMed ID: 1296432
    [Abstract] [Full Text] [Related]

  • 25. Somatostatin pretreatment enhances growth hormone (GH) responsiveness to GH-releasing hormone: a potential new diagnostic approach to GH deficiency.
    Tzanela M, Guyda H, Van Vliet G, Tannenbaum GS.
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2487-94. PubMed ID: 8675565
    [Abstract] [Full Text] [Related]

  • 26. Clinical diagnoses of children with extremely short stature and their response to growth hormone.
    Moore KC, Donaldson DL, Ideus PL, Gifford RA, Moore WV.
    J Pediatr; 1993 May; 122(5 Pt 1):687-92. PubMed ID: 8496743
    [Abstract] [Full Text] [Related]

  • 27. Growth hormone response to hpGRF-40 in different forms of growth retardation and endocrine-metabolic diseases.
    Pintor C, Loche S, Puggioni R, Cella SG, Locatelli V, Villa F, Corda R, Müller EE.
    Eur J Pediatr; 1986 Feb; 144(5):475-81. PubMed ID: 3082639
    [Abstract] [Full Text] [Related]

  • 28. Endocrinological differentiation of primary hypothalamic and pituitary disease.
    Müller EE.
    Acta Neurochir (Wien); 1985 Feb; 75(1-4):91-8. PubMed ID: 2986426
    [Abstract] [Full Text] [Related]

  • 29. Response to repetitive luteinizing hormone-releasing hormone stimulation in hypothalamic and pituitary disease.
    Wentz AC, Andersen RN.
    Am J Obstet Gynecol; 1980 Oct 15; 138(4):364-8. PubMed ID: 6999906
    [Abstract] [Full Text] [Related]

  • 30. Plasma growth hormone (GH) response to GH-releasing factor in normal children with short stature and patients with pituitary dwarfism.
    Takano K, Hizuka N, Shizume K, Asakawa K, Miyakawa M, Hirose N, Shibasaki T, Ling NC.
    J Clin Endocrinol Metab; 1984 Feb 15; 58(2):236-41. PubMed ID: 6420432
    [Abstract] [Full Text] [Related]

  • 31. Plasma growth hormone (GH) response to GH-releasing factor (SM-8144) in children of short stature and patients with GH deficiency.
    Takano K, Shizume K, Imura H, Irie M, Kumahara Y, Shimizu N.
    Endocrinol Jpn; 1987 Feb 15; 34(1):117-28. PubMed ID: 3111840
    [Abstract] [Full Text] [Related]

  • 32. Insulin hypoglycemia test and releasing hormone (corticotropin-releasing hormone and growth hormone-releasing hormone) stimulation in patients with pituitary failure of different origin.
    Stalla GK, Losa M, Oeckler R, Müller OA, von Werder K.
    Horm Res; 1988 Feb 15; 29(5-6):191-6. PubMed ID: 2851521
    [Abstract] [Full Text] [Related]

  • 33. [Growth hormone secretion following administration of growth hormone releasing hormone in constitutional short stature and idiopathic growth hormone deficiency].
    Butenandt O, Kiess W.
    Monatsschr Kinderheilkd; 1987 Feb 15; 135(2):114-5. PubMed ID: 3106789
    [Abstract] [Full Text] [Related]

  • 34. LH and FSH responsiveness to intravenous gonadotropin-releasing hormone (GnRH) in children with hypothalamic or pituitary disorders: lack of effect of replacement therapy with human growth hormone.
    Kelch RP, Markovs M, Huss J.
    J Clin Endocrinol Metab; 1976 Jun 15; 42(6):1104-13. PubMed ID: 777020
    [Abstract] [Full Text] [Related]

  • 35. Absence of growth hormone (GH) secretion after the administration of either GH-releasing hormone (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary stalk transection.
    Pombo M, Barreiro J, Peñalva A, Peino R, Dieguez C, Casanueva FF.
    J Clin Endocrinol Metab; 1995 Nov 15; 80(11):3180-4. PubMed ID: 7593423
    [Abstract] [Full Text] [Related]

  • 36. [Behavior of growth hormone after stimulation with growth hormone releasing hormone (GHRH) in children with disorders of the hypothalamo-hypophyseal axis and girls with Turner syndrome].
    Schmitt K, Schober E, Birnbacher R, Frisch H.
    Klin Padiatr; 1996 Nov 15; 208(1):29-34. PubMed ID: 8851324
    [Abstract] [Full Text] [Related]

  • 37. The effect of hexarelin on growth hormone (GH) secretion in patients with GH deficiency.
    Loche S, Cambiaso P, Merola B, Colao A, Faedda A, Imbimbo BP, Deghenghi R, Lombardi G, Cappa M.
    J Clin Endocrinol Metab; 1995 Sep 15; 80(9):2692-6. PubMed ID: 7673411
    [Abstract] [Full Text] [Related]

  • 38. Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities.
    Varga JL, Schally AV, Csernus VJ, Zarándi M, Halmos G, Groot K, Rékási Z.
    Proc Natl Acad Sci U S A; 1999 Jan 19; 96(2):692-7. PubMed ID: 9892695
    [Abstract] [Full Text] [Related]

  • 39. Chronic administration of a new potent agonist of growth hormone- releasing hormone induces compensatory linear growth in growth hormone-deficient rats: mechanism of action.
    Kovács M, Halmos G, Groot K, Izdebski J, Schally AV.
    Neuroendocrinology; 1996 Sep 19; 64(3):169-76. PubMed ID: 8875434
    [Abstract] [Full Text] [Related]

  • 40. Plasma growth hormone (GH) responses to single and repetitive subcutaneous administration of GH releasing factor (hpGRF-44) in normal and GH deficient children.
    Takano K, Hizuka N, Shizume K, Honda N, Ling NC.
    Acta Endocrinol (Copenh); 1985 Jan 19; 108(1):11-9. PubMed ID: 3918397
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.